Tizanidine Hydrochloride 75834-0208-15
- Manufacturer
- Nivagen Pharmaceuticals, Inc.
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- September 26, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA210021
Need to source Tizanidine Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tizanidine Hydrochloride | 4 mg/1 |
Drug Class
Adrenergic alpha2-Agonists [MoA]Central alpha-2 Adrenergic Agonist [EPC]
Selected Package
75834-0208-15Selected150 CAPSULE in 1 BOTTLE (75834-208-15)